
Cardinal Health statistics
$281.10+1.06%Close 13 Nov 2026 · Market value $65.30B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Cardinal Health is valued at $65.30B on its latest close. Its price is 35.9 times its earnings.
| Market value | $65.30B |
|---|
| Enterprise value | $68.68B |
|---|
| Price / earnings | 35.92 |
|---|
| Price / sales | 0.25 |
|---|
| EV / EBITDA | 18.72 |
|---|
| EV / sales | 0.27 |
|---|
| Price / free cash flow | 13.32 |
|---|
| Price / free cash flow, own 5-year average | 12.17 |
|---|
| EV / EBIT | 25.52 |
|---|
| EV / free cash flow | 14.05 |
|---|
| Free cash flow yield | 7.5% |
|---|
| Dividend yield | 0.7% |
|---|
Share price
| Latest close | $281.10 |
|---|
| Day's change | +1.1% |
|---|
| 52-week high | $286.29 |
|---|
| 52-week low | $180.45 |
|---|
| From 52-week high | −1.8% |
|---|
| Return · 1 month | +10.6% |
|---|
| Return · 3 months | +23.0% |
|---|
| Return · year to date | +36.8% |
|---|
| Return · 1 year | +37.6% |
|---|
| Beta · 1 year against the S&P 500 | −0.02 |
|---|
| 50-day average | $244.19 |
|---|
| 200-day average | $225.10 |
|---|
| RSI 14 | 78.8 |
|---|
| Average volume · 20 sessions | 1.8M |
|---|
Margins and returns
For fiscal 2026, as filed.
| Gross margin | 3.8% |
|---|
| Operating margin | 1.0% |
|---|
| Net margin | 0.7% |
|---|
| Free cash flow margin | 1.8% |
|---|
| Return on assets | 3.7% |
|---|
| Return on invested capital | 13.4% |
|---|
| Return on invested capital, 5-year average | 7.1% |
|---|
| Return on capital employed | 18.9% |
|---|
| Stock-based compensation / revenue | 0.1% |
|---|
Financial position
At the end of fiscal 2026.
| Cash and equivalents | $4.86B |
|---|
| Total debt | $9.95B |
|---|
| Net debt | $5.09B |
|---|
| Current ratio | 0.88 |
|---|
| Quick ratio | 0.11 |
|---|
| Net debt / EBITDA | 1.43 |
|---|
| Interest coverage | 7.51 |
|---|
Growth
| Revenue, latest quarter on a year | +5.5% |
|---|
| Revenue, twelve months on a year | +10.0% |
|---|
| EPS, latest quarter on a year | +26.6% |
|---|
| EPS, twelve months on a year | +16.6% |
|---|
| Revenue, 5-year compound | +9.4% |
|---|
| Revenue, 10-year compound | +7.7% |
|---|
| Net income, 5-year compound | +22.9% |
|---|
| Free cash flow, 5-year compound | +17.4% |
|---|
| EPS, 5-year compound | +28.3% |
|---|
Shares and dividends
For fiscal 2026, as filed.
| Diluted shares | 237M |
|---|
| Shares outstanding, 5-year compound | −4.2% |
|---|
| Net share repurchases | $1.36B |
|---|
| Dividends per share | $2.04 |
|---|
| Dividend payout | 28.6% |
|---|
Taxes
For fiscal 2026, as filed.
| Income tax expense | $469.0M |
|---|
| Effective tax rate | 21.6% |
|---|
CAH in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.